Literature DB >> 8747772

Post-transplant lymphoproliferative disorder.

N Basgoz1, J K Preiksaitis.   

Abstract

This article discusses the virology of Epstein-Barr virus (EBV) and provides an overview of the disease states associated with the virus, describes how the immunology of EBV infection provides for control in the normal host, and reviews what is currently known about post-transplant lymphoproliferative disorder (PTLD), including evidence for EBV in the pathogenesis of PTLD, risk factors for its development, clinical presentation, methods for diagnosis, pathology, treatment, and current and future preventive strategies.

Entities:  

Mesh：

Year:  1995        PMID： 8747772

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN： 0891-5520            Impact factor:   5.982


  14 in total

Review 1.  Central nervous system infection during immunosuppression.

Authors:  Joseph R Zunt
Journal:  Neurol Clin       Date:  2002-02       Impact factor: 3.806

Review 2.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 3.  Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.

Authors:  M T LaRocco; S J Burgert
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

4.  Predictive value of quantitative PCR-based viral burden analysis for eight human herpesviruses in pediatric solid organ transplant patients.

Authors:  X Bai; B B Rogers; P C Harkins; J Sommerauer; R Squires; K Rotondo; A Quan; D B Dawson; R H Scheuermann
Journal:  J Mol Diagn       Date:  2000-11       Impact factor: 5.568

Review 5.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

6.  Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression.

Authors:  R Shapiro; M Nalesnik; J McCauley; S Fedorek; M L Jordan; V P Scantlebury; A Jain; C Vivas; D Ellis; S Lombardozzi-Lane; P Randhawa; J Johnston; T R Hakala; R L Simmons; J J Fung; T E Starzl
Journal:  Transplantation       Date:  1999-12-27       Impact factor: 4.939

7.  American Society of Nephrology Quiz and Questionnaire 2013: transplantation.

Authors:  Michelle A Josephson; Mark A Perazella; Michael J Choi
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-17       Impact factor: 8.237

8.  Posttransplantation lymphoproliferative disorder of the paranasal sinuses mimicking invasive fungal sinusitis: case report.

Authors:  Andrew R Gordon; Laurie A Loevner; Adina I Sonners; William E Bolger; Mariusz A Wasik
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

9.  EBV Latency III-Transformed B Cells Are Inducers of Conventional and Unconventional Regulatory T Cells in a PD-L1-Dependent Manner.

Authors:  Héloïse Auclair; Catherine Ouk-Martin; Lilian Roland; Pauline Santa; Hazar Al Mohamad; Nathalie Faumont; Jean Feuillard; Chantal Jayat-Vignoles
Journal:  J Immunol       Date:  2019-08-21       Impact factor: 5.422

Review 10.  The post-transplant lymphoproliferative disorder-a literature review.

Authors:  Rokshana Shroff; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2004-02-21       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.